Cargando…

E-cadherin and K-ras: implications of a newly developed model of gastric cancer

Detalles Bibliográficos
Autores principales:	Till, Jacob E., Yoon, Sam S., Ryeom, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769975/ https://www.ncbi.nlm.nih.gov/pubmed/29344549 http://dx.doi.org/10.18632/oncoscience.379

Ejemplares similares

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations
por: Corso, Giovanni, et al.
Publicado: (2020)

N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN
por: Su, Yanrong, et al.
Publicado: (2015)

Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications
por: Zhao, Huichen, et al.
Publicado: (2021)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023)

KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis
por: Yoon, Changhwan, et al.
Publicado: (2023)

Gastric Cancer and the Immune System: The Key to Improving Outcomes?
por: Keshavjee, Sara H., et al.
Publicado: (2022)

PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance
por: Yoon, Changhwan, et al.
Publicado: (2021)

The expressions and prognostic implications of Twist and E-cadherin in adenocarcinomas of the gastroesophageal junction and proximal gastric carcinoma
por: Sun, Shengbo, et al.
Publicado: (2019)

Alterations of E-cadherin and β-catenin in gastric cancer
por: Huiping, Chen, et al.
Publicado: (2001)

E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications
por: Liu, Xin, et al.
Publicado: (2014)

Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer
por: Lin, Zhaohu, et al.
Publicado: (2014)

ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus‐dependent E‐cadherin downregulation
por: Otake, Shigeo, et al.
Publicado: (2020)

PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
por: Yoon, Changhwan, et al.
Publicado: (2021)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

Intercellular transfer of Ras: Implications for immunity
por: Goldstein, Itamar, et al.
Publicado: (2014)

K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness
por: Manoharan, Ganesh babu, et al.
Publicado: (2023)

Comparison of K-ras mutations in lung, colorectal and gastric cancer
por: PENG, NANQIU, et al.
Publicado: (2014)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

E-cadherin mediated cellular effects and molecular partners. Gastric cancer as an invasive model
por: Figueiredo, Joana, et al.
Publicado: (2010)

Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin–p120-Catenin Complex
por: Park, So-Yeon, et al.
Publicado: (2017)

Inactivation of the E‐Cadherin Gene in Primary Gastric Carcinomas and Gastric Carcinoma Cell Lines
por: Tamura, Gen, et al.
Publicado: (1996)

Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin
Publicado: (1992)

E-Cadherin Can Replace N-Cadherin during Secretory-Stage Enamel Development
por: Guan, Xiaomu, et al.
Publicado: (2014)

Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid.
por: Matsuura, K., et al.
Publicado: (1992)

Prognostic significance of E-cadherin/catenin complex expression in gastric cancer.
por: Joo, Y. E., et al.
Publicado: (2000)

Epstein-Barr Virus, Beta-Catenin, and E-cadherin in Gastric Carcinomas
por: Jung, In Mok, et al.
Publicado: (2007)

E-cadherin Expression in Canine Gastric Carcinomas: Association with Clinicopathological Parameters
por: Flores, Ana R., et al.
Publicado: (2022)

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
por: Creţu, Oana Iulia, et al.
Publicado: (2022)

Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014)

FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression
por: Hardy, Katharine M, et al.
Publicado: (2011)

Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug
por: Khan, Poulami, et al.
Publicado: (2016)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

Modeling and subtleties of K-Ras and Calmodulin interaction
por: Garrido, Eduardo, et al.
Publicado: (2018)

Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer
por: Eom, Bang Wool, et al.
Publicado: (2020)

Effect of Cadherin-11 Expression on the Prognosis of a Newly Diagnosed Primary Glioblastoma
por: Seo, Hyunwoo, et al.
Publicado: (2021)

M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell–cell adhesion during collective cell migration
por: Kota, Pradeep, et al.
Publicado: (2019)

EXPRESSION OF E-CADHERIN AND WNT PATHWAY PROTEINS BETACATENIN, APC, TCF-4 AND SURVIVIN IN GASTRIC ADENOCARCINOMA: CLINICAL AND PATHOLOGICAL IMPLICATION
por: LINS, Rodrigo Rego, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k989jqd97p43bmcr4l5tq9qrug